Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report elaborates on the current development of the Pharmaceutical CDMO Services industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
By Player:
AMRI
WuXi AppTec Group
Siegfried
Fareva
Boehringer Ingelheim
Catalent
FAMAR Health Care Services
Eurofins CDMO
Patheon
Piramal Pharma Solutions
Aenova
By Type:
Secondary Packaging
Active Pharmaceutical Ingredient (API) Manufacturing
Finished Dosage Formulation (FDF) Development & Manufacturing
By Application:
Phase III
Phase IV
Phase II
Pre-clinical
Phase I
By Research Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
Chapter 1 China Pharmaceutical CDMO Services Market Overview 2018-2029
-
1.1 China Pharmaceutical CDMO Services Industry Development Overview
-
1.2 China Pharmaceutical CDMO Services Industry Development History
-
1.3 China Pharmaceutical CDMO Services Industry Market Size (2018-2029)
-
1.4 China Pharmaceutical CDMO Services Market Analysis by Type from Production Side
-
1.4.1 China Pharmaceutical CDMO Services Production Volume, Production Value and Growth Rate of Secondary Packaging (2018-2029)
-
1.4.2 China Pharmaceutical CDMO Services Production Volume, Production Value and Growth Rate of Active Pharmaceutical Ingredient (API) Manufacturing (2018-2029)
-
1.4.3 China Pharmaceutical CDMO Services Production Volume, Production Value and Growth Rate of Finished Dosage Formulation (FDF) Development & Manufacturing (2018-2029)
-
1.5 China Pharmaceutical CDMO Services Market Analysis by Application from Consumption End
-
1.5.1 China Pharmaceutical CDMO Services Sales Volume, Sales Value and Growth Rate of Phase III (2018-2029)
-
1.5.2 China Pharmaceutical CDMO Services Sales Volume, Sales Value and Growth Rate of Phase IV (2018-2029)
-
1.5.3 China Pharmaceutical CDMO Services Sales Volume, Sales Value and Growth Rate of Phase II (2018-2029)
-
1.5.4 China Pharmaceutical CDMO Services Sales Volume, Sales Value and Growth Rate of Pre-clinical (2018-2029)
-
1.5.5 China Pharmaceutical CDMO Services Sales Volume, Sales Value and Growth Rate of Phase I (2018-2029)
-
1.6 China Pharmaceutical CDMO Services Market Analysis by Region
-
1.6.1 North China Pharmaceutical CDMO Services Market Size and Growth Rate from 2018-2029
-
1.6.2 Central China Pharmaceutical CDMO Services Market Size and Growth Rate from 2018-2029
-
1.6.3 South China Pharmaceutical CDMO Services Market Size and Growth Rate from 2018-2029
-
1.6.4 East China Pharmaceutical CDMO Services Market Size and Growth Rate from 2018-2029
-
1.6.5 Northeast China Pharmaceutical CDMO Services Market Size and Growth Rate from 2018-2029
-
1.6.6 Southwest China Pharmaceutical CDMO Services Market Size and Growth Rate from 2018-2029
-
1.6.7 Northwest China Pharmaceutical CDMO Services Market Size and Growth Rate from 2018-2029
Chapter 2 China Pharmaceutical CDMO Services Industry Development Environment
-
2.1 Industry Development Environment Analysis
-
2.1.1 Industry Technological Progress Analysis
-
2.1.2 Industrial Organizational Innovation Analysis
-
2.1.3 Changes in Social Habits
-
2.1.4 Alterations in Government Policies
-
2.1.5 Impact of Economic Globalization
-
2.2 Domestic and Foreign Industry Competition Analysis
-
2.2.1 Comparative Analysis on Pharmaceutical CDMO Services Market Status and Competition at home and abroad in 2023
-
2.2.2 China Pharmaceutical CDMO Services Market Status and Competition Analysis in 2023
-
2.2.3 China Pharmaceutical CDMO Services Market Concentration Analysis in 2023
-
2.3 Problems and Countermeasures in the development of China Pharmaceutical CDMO Services Industry
-
2.3.1 Industry Development Constraints
-
2.3.2 Industry Development Considerations
-
2.3.3 Suggestions on Industry Development Measures
-
2.3.4 Development Strategies for SMEs
-
2.4 Influence of COVID-19 Outbreak on Pharmaceutical CDMO Services Industry Development
Chapter 3 Pharmaceutical CDMO ServicesIndustry Chain Analysis
-
3.1 Pharmaceutical CDMO Services Industry Chain
-
3.2 Pharmaceutical CDMO Services Upstream Industry Analysis
-
3.2.1 Upstream Industry Development Status
-
3.2.2 Upstream Industry Development Forecast
-
3.2.3 Impact of Upstream Industry on the Pharmaceutical CDMO Services Market
-
3.3 Pharmaceutical CDMO Services Downstream Industry Analysis
-
3.3.1 Downstream Industry Development Status
-
3.3.2 Downstream Industry Development Forecast
-
3.3.3 Impact of Downstream Industry on the Pharmaceutical CDMO Services Market
Chapter 4 China Pharmaceutical CDMO Services Market, by Type
-
4.1 China Pharmaceutical CDMO Services Market Trend, by Type
-
4.2 Product Types of Major Suppliers
-
4.3 Competitive Landscape of Major Types
-
4.4 China Pharmaceutical CDMO Services Total Production Volume and Growth Rate from Production Side
-
4.5 China Pharmaceutical CDMO Services Production Volume and Growth Rate, by Type
-
4.5.1 China Pharmaceutical CDMO Services Production Volume and Growth Rate of Secondary Packaging
-
4.5.2 China Pharmaceutical CDMO Services Production Volume and Growth Rate of Active Pharmaceutical Ingredient (API) Manufacturing
-
4.5.3 China Pharmaceutical CDMO Services Production Volume and Growth Rate of Finished Dosage Formulation (FDF) Development & Manufacturing
Chapter 5 China Pharmaceutical CDMO Services Market, by Application
-
5.1 Downstream Market Overview
-
5.2 Competitive Landscape of Major Applications
-
5.3 Market Potential Analysis, by Application
-
5.4 China Pharmaceutical CDMO Services Total Market Size and Growth Rate from Consumption End
-
5.5 China Pharmaceutical CDMO Services Market Size and Growth Rate, by Application
-
5.5.1 China Pharmaceutical CDMO Services Market Size and Growth Rate of Phase III
-
5.5.2 China Pharmaceutical CDMO Services Market Size and Growth Rate of Phase IV
-
5.5.3 China Pharmaceutical CDMO Services Market Size and Growth Rate of Phase II
-
5.5.4 China Pharmaceutical CDMO Services Market Size and Growth Rate of Pre-clinical
-
5.5.5 China Pharmaceutical CDMO Services Market Size and Growth Rate of Phase I
Chapter 6 China Pharmaceutical CDMO Services Market, by Region
-
6.1 China Pharmaceutical CDMO Services Production Volume and Production Value, by Region
-
6.2 China Pharmaceutical CDMO Services Sales Volume and Sales Value, by Region
Chapter 7 North China Pharmaceutical CDMO Services Market Analysis
-
7.1 North China Pharmaceutical CDMO Services Market, by Type
-
7.2 North China Pharmaceutical CDMO Services Market, by Application
Chapter 8 Central China Pharmaceutical CDMO Services Market Analysis
-
8.1 Central China Pharmaceutical CDMO Services Market, by Type
-
8.2 Central China Pharmaceutical CDMO Services Market, by Application
Chapter 9 South China Pharmaceutical CDMO Services Market Analysis
-
9.1 South China Pharmaceutical CDMO Services Market, by Type
-
9.2 South China Pharmaceutical CDMO Services Market, by Application
Chapter 10 East China Pharmaceutical CDMO Services Market Analysis
-
10.1 East China Pharmaceutical CDMO Services Market, by Type
-
10.2 East China Pharmaceutical CDMO Services Market, by Application
Chapter 11 Northeast China Pharmaceutical CDMO Services Market Analysis
-
11.1 Northeast China Pharmaceutical CDMO Services Market, by Type
-
11.2 Northeast China Pharmaceutical CDMO Services Market, by Application
Chapter 12 Southwest China Pharmaceutical CDMO Services Market Analysis
-
12.1 Southwest China Pharmaceutical CDMO Services Market, by Type
-
12.2 Southwest China Pharmaceutical CDMO Services Market, by Application
Chapter 13 Northwest China Pharmaceutical CDMO Services Market Analysis
-
13.1 Northwest China Pharmaceutical CDMO Services Market, by Type
-
13.2 Northwest China Pharmaceutical CDMO Services Market, by Application
Chapter 14 Company Profiles
-
14.1 AMRI
-
14.1.1 AMRI Company Profile
-
14.1.2 AMRI Pharmaceutical CDMO Services Market Performance
-
14.1.3 Product&Service Introduction
-
14.2 WuXi AppTec Group
-
14.2.1 WuXi AppTec Group Company Profile
-
14.2.2 WuXi AppTec Group Pharmaceutical CDMO Services Market Performance
-
14.2.3 Product&Service Introduction
-
14.3 Siegfried
-
14.3.1 Siegfried Company Profile
-
14.3.2 Siegfried Pharmaceutical CDMO Services Market Performance
-
14.3.3 Product&Service Introduction
-
14.4 Fareva
-
14.4.1 Fareva Company Profile
-
14.4.2 Fareva Pharmaceutical CDMO Services Market Performance
-
14.4.3 Product&Service Introduction
-
14.5 Boehringer Ingelheim
-
14.5.1 Boehringer Ingelheim Company Profile
-
14.5.2 Boehringer Ingelheim Pharmaceutical CDMO Services Market Performance
-
14.5.3 Product&Service Introduction
-
14.6 Catalent
-
14.6.1 Catalent Company Profile
-
14.6.2 Catalent Pharmaceutical CDMO Services Market Performance
-
14.6.3 Product&Service Introduction
-
14.7 FAMAR Health Care Services
-
14.7.1 FAMAR Health Care Services Company Profile
-
14.7.2 FAMAR Health Care Services Pharmaceutical CDMO Services Market Performance
-
14.7.3 Product&Service Introduction
-
14.8 Eurofins CDMO
-
14.8.1 Eurofins CDMO Company Profile
-
14.8.2 Eurofins CDMO Pharmaceutical CDMO Services Market Performance
-
14.8.3 Product&Service Introduction
-
14.9 Patheon
-
14.9.1 Patheon Company Profile
-
14.9.2 Patheon Pharmaceutical CDMO Services Market Performance
-
14.9.3 Product&Service Introduction
-
14.10 Piramal Pharma Solutions
-
14.10.1 Piramal Pharma Solutions Company Profile
-
14.10.2 Piramal Pharma Solutions Pharmaceutical CDMO Services Market Performance
-
14.10.3 Product&Service Introduction
-
14.11 Aenova
-
14.11.1 Aenova Company Profile
-
14.11.2 Aenova Pharmaceutical CDMO Services Market Performance
-
14.11.3 Product&Service Introduction
Chapter 15 Research Conclusions and Investment Suggestions
-
15.1 Pharmaceutical CDMO Services Industry Research Conclusions
-
15.2 Pharmaceutical CDMO Services Industry Investment Suggestions
-
15.2.1 Suggestions on Industry Development Strategy
-
15.2.2 Suggestions on Industry Investment Direction
-
15.2.3 Suggestions on Industry Investment Strategy
List of Tables and Figures
-
Figure China Pharmaceutical CDMO Services Industry Market Size (2018-2029)
-
Figure China Pharmaceutical CDMO Services Production Volume, Production Value and Growth Rate of Secondary Packaging (2018-2029)
-
Figure China Pharmaceutical CDMO Services Production Volume, Production Value and Growth Rate of Active Pharmaceutical Ingredient (API) Manufacturing (2018-2029)
-
Figure China Pharmaceutical CDMO Services Production Volume, Production Value and Growth Rate of Finished Dosage Formulation (FDF) Development & Manufacturing (2018-2029)
-
Figure China Pharmaceutical CDMO Services Sales Volume, Sales Value and Growth Rate of Phase III (2018-2029)
-
Figure China Pharmaceutical CDMO Services Sales Volume, Sales Value and Growth Rate of Phase IV (2018-2029)
-
Figure China Pharmaceutical CDMO Services Sales Volume, Sales Value and Growth Rate of Phase II (2018-2029)
-
Figure China Pharmaceutical CDMO Services Sales Volume, Sales Value and Growth Rate of Pre-clinical (2018-2029)
-
Figure China Pharmaceutical CDMO Services Sales Volume, Sales Value and Growth Rate of Phase I (2018-2029)
-
Figure North China Pharmaceutical CDMO Services Market Size and Growth Rate from 2018-2029
-
Figure Central China Pharmaceutical CDMO Services Market Size and Growth Rate from 2018-2029
-
Figure South China Pharmaceutical CDMO Services Market Size and Growth Rate from 2018-2029
-
Figure East China Pharmaceutical CDMO Services Market Size and Growth Rate from 2018-2029
-
Figure Northeast China Pharmaceutical CDMO Services Market Size and Growth Rate from 2018-2029
-
Figure Southwest China Pharmaceutical CDMO Services Market Size and Growth Rate from 2018-2029
-
Figure Northwest China Pharmaceutical CDMO Services Market Size and Growth Rate from 2018-2029
-
Figure Pharmaceutical CDMO Services Industry Chain
-
Table Product Types of Major Suppliers in 2023
-
Figure China Pharmaceutical CDMO Services Market Share by Type in 2018
-
Figure China Pharmaceutical CDMO Services Market Share by Type in 2023
-
Figure China Pharmaceutical CDMO Services Total Production Volume and Growth Rate from Production Side (2018-2023)
-
Figure China Pharmaceutical CDMO Services Production Volume and Growth Rate of Secondary Packaging (2018-2023)
-
Figure China Pharmaceutical CDMO Services Production Volume and Growth Rate of Active Pharmaceutical Ingredient (API) Manufacturing (2018-2023)
-
Figure China Pharmaceutical CDMO Services Production Volume and Growth Rate of Finished Dosage Formulation (FDF) Development & Manufacturing (2018-2023)
-
Figure China Pharmaceutical CDMO Services Market Share by Application in 2018
-
Figure China Pharmaceutical CDMO Services Market Share by Application in 2023
-
Figure China Pharmaceutical CDMO Services Total Market Size and Growth Rate from Consumption End
-
Figure China Pharmaceutical CDMO Services Market Size and Growth Rate of Phase III (2018-2023)
-
Figure China Pharmaceutical CDMO Services Market Size and Growth Rate of Phase IV (2018-2023)
-
Figure China Pharmaceutical CDMO Services Market Size and Growth Rate of Phase II (2018-2023)
-
Figure China Pharmaceutical CDMO Services Market Size and Growth Rate of Pre-clinical (2018-2023)
-
Figure China Pharmaceutical CDMO Services Market Size and Growth Rate of Phase I (2018-2023)
-
Table China Pharmaceutical CDMO Services Production Volume by Region (2018-2023)
-
Table China Pharmaceutical CDMO Services Production Volume Share by Region (2018-2023)
-
Figure China Pharmaceutical CDMO Services Production Volume Share by Region (2018-2023)
-
Table China Pharmaceutical CDMO Services Production Value by Region (2018-2023)
-
Table China Pharmaceutical CDMO Services Production Value Share by Region (2018-2023)
-
Figure China Pharmaceutical CDMO Services Production Value Share by Region (2018-2023)
-
Table China Pharmaceutical CDMO Services Sales Volume by Region (2018-2023)
-
Table China Pharmaceutical CDMO Services Sales Volume Share by Region (2018-2023)
-
Figure China Pharmaceutical CDMO Services Sales Volume Share by Region (2018-2023)
-
Table China Pharmaceutical CDMO Services Sales Value by Region (2018-2023)
-
Table China Pharmaceutical CDMO Services Sales Value Share by Region (2018-2023)
-
Figure China Pharmaceutical CDMO Services Sales Value Share by Region (2018-2023)
-
Table North China Pharmaceutical CDMO Services Production Volume by Type (2018-2023)
-
Table North China Pharmaceutical CDMO Services Production Volume Share by Type (2018-2023)
-
Figure North China Pharmaceutical CDMO Services Production Volume Share by Type (2018-2023)
-
Table North China Pharmaceutical CDMO Services Sales Volume by Application (2018-2023)
-
Table North China Pharmaceutical CDMO Services Sales Volume Share by Application (2018-2023)
-
Figure North China Pharmaceutical CDMO Services Sales Volume Share by Application (2018-2023)
-
Table Central China Pharmaceutical CDMO Services Production Volume by Type (2018-2023)
-
Table Central China Pharmaceutical CDMO Services Production Volume Share by Type (2018-2023)
-
Figure Central China Pharmaceutical CDMO Services Production Volume Share by Type (2018-2023)
-
Table Central China Pharmaceutical CDMO Services Sales Volume by Application (2018-2023)
-
Table Central China Pharmaceutical CDMO Services Sales Volume Share by Application (2018-2023)
-
Figure Central China Pharmaceutical CDMO Services Sales Volume Share by Application (2018-2023)
-
Table South China Pharmaceutical CDMO Services Production Volume by Type (2018-2023)
-
Table South China Pharmaceutical CDMO Services Production Volume Share by Type (2018-2023)
-
Figure South China Pharmaceutical CDMO Services Production Volume Share by Type (2018-2023)
-
Table South China Pharmaceutical CDMO Services Sales Volume by Application (2018-2023)
-
Table South China Pharmaceutical CDMO Services Sales Volume Share by Application (2018-2023)
-
Figure South China Pharmaceutical CDMO Services Sales Volume Share by Application (2018-2023)
-
Table East China Pharmaceutical CDMO Services Production Volume by Type (2018-2023)
-
Table East China Pharmaceutical CDMO Services Production Volume Share by Type (2018-2023)
-
Figure East China Pharmaceutical CDMO Services Production Volume Share by Type (2018-2023)
-
Table East China Pharmaceutical CDMO Services Sales Volume by Application (2018-2023)
-
Table East China Pharmaceutical CDMO Services Sales Volume Share by Application (2018-2023)
-
Figure East China Pharmaceutical CDMO Services Sales Volume Share by Application (2018-2023)
-
Table Northeast China Pharmaceutical CDMO Services Production Volume by Type (2018-2023)
-
Table Northeast China Pharmaceutical CDMO Services Production Volume Share by Type (2018-2023)
-
Figure Northeast China Pharmaceutical CDMO Services Production Volume Share by Type (2018-2023)
-
Table Northeast China Pharmaceutical CDMO Services Sales Volume by Application (2018-2023)
-
Table Northeast China Pharmaceutical CDMO Services Sales Volume Share by Application (2018-2023)
-
Figure Northeast China Pharmaceutical CDMO Services Sales Volume Share by Application (2018-2023)
-
Table Southwest China Pharmaceutical CDMO Services Production Volume by Type (2018-2023)
-
Table Southwest China Pharmaceutical CDMO Services Production Volume Share by Type (2018-2023)
-
Figure Southwest China Pharmaceutical CDMO Services Production Volume Share by Type (2018-2023)
-
Table Southwest China Pharmaceutical CDMO Services Sales Volume by Application (2018-2023)
-
Table Southwest China Pharmaceutical CDMO Services Sales Volume Share by Application (2018-2023)
-
Figure Southwest China Pharmaceutical CDMO Services Sales Volume Share by Application (2018-2023)
-
Table Northwest China Pharmaceutical CDMO Services Production Volume by Type (2018-2023)
-
Table Northwest China Pharmaceutical CDMO Services Production Volume Share by Type (2018-2023)
-
Figure Northwest China Pharmaceutical CDMO Services Production Volume Share by Type (2018-2023)
-
Table Northwest China Pharmaceutical CDMO Services Sales Volume by Application (2018-2023)
-
Table Northwest China Pharmaceutical CDMO Services Sales Volume Share by Application (2018-2023)
-
Figure Northwest China Pharmaceutical CDMO Services Sales Volume Share by Application (2018-2023)
-
Table AMRI Company Profile
-
Table AMRI Pharmaceutical CDMO Services Revenue, Price and Gross (2018-2023)
-
Table WuXi AppTec Group Company Profile
-
Table WuXi AppTec Group Pharmaceutical CDMO Services Revenue, Price and Gross (2018-2023)
-
Table Siegfried Company Profile
-
Table Siegfried Pharmaceutical CDMO Services Revenue, Price and Gross (2018-2023)
-
Table Fareva Company Profile
-
Table Fareva Pharmaceutical CDMO Services Revenue, Price and Gross (2018-2023)
-
Table Boehringer Ingelheim Company Profile
-
Table Boehringer Ingelheim Pharmaceutical CDMO Services Revenue, Price and Gross (2018-2023)
-
Table Catalent Company Profile
-
Table Catalent Pharmaceutical CDMO Services Revenue, Price and Gross (2018-2023)
-
Table FAMAR Health Care Services Company Profile
-
Table FAMAR Health Care Services Pharmaceutical CDMO Services Revenue, Price and Gross (2018-2023)
-
Table Eurofins CDMO Company Profile
-
Table Eurofins CDMO Pharmaceutical CDMO Services Revenue, Price and Gross (2018-2023)
-
Table Patheon Company Profile
-
Table Patheon Pharmaceutical CDMO Services Revenue, Price and Gross (2018-2023)
-
Table Piramal Pharma Solutions Company Profile
-
Table Piramal Pharma Solutions Pharmaceutical CDMO Services Revenue, Price and Gross (2018-2023)
-
Table Aenova Company Profile
-
Table Aenova Pharmaceutical CDMO Services Revenue, Price and Gross (2018-2023)
-
